Top Chronic Myelogenous Leukemia Treatment Companies, Leaders & Major Players

This list of the top companies of Chronic Myelogenous Leukemia Treatment is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Chronic Myelogenous Leukemia Treatment sector.

Top Chronic Myelogenous Leukemia Treatment Companies

  1. Bristol-Myers Squibb

  2. Pfizer

  3. Teva Pharmaceutical Industries

  4. Takeda Pharmaceuticals

  5. Novartis

*Disclaimer: Top companies sorted in no particular order

Chronic Myelogenous Leukemia Treatment Market Major Players

Chronic Myelogenous Leukemia Treatment - Competitive Concentration

Chronic Myelogenous Leukemia Treatment Market Concentration

List of Chronic Myelogenous Leukemia Treatment Companies

  • Novartis

  • Bristol-Myers Squibb

  • Pfizer

  • Takeda Pharmaceuticals

  • Incyte Corp.

  • Merck

  • Roche

  • Sanofi

  • Boehringer Ingelheim

  • Teva Pharmaceutical Industries

  • Viatris

  • Cipla

  • Amneal Pharmaceuticals

  • Accord Healthcare

  • Fresenius

  • Ascentage Pharma Group Corp.

  • Hansoh Pharmaceutical Group Co. Ltd.

  • Sun Pharma Industries Ltd.

  • Dr. Reddy’s Laboratories Ltd.

  • Hikma Pharmaceuticals

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds